How to Get Provigil (Modafinil) in Massachusetts

Prescription access and medication affordability image for How to Get Provigil (Modafinil) in Massachusetts

At a glance

  • Drug / modafinil (Provigil), Schedule IV controlled substance
  • FDA-approved indications / narcolepsy, obstructive sleep apnea residual sleepiness, shift-work disorder
  • Massachusetts telehealth prescribing / permitted for Schedule IV substances
  • MassHealth (Medicaid) / covered with prior authorization
  • Prescribers / MD, DO, NP (with collaborative agreement), PA
  • Dose form / 100 mg and 200 mg oral tablets, taken once each morning
  • Generic availability / yes, multiple manufacturers since 2012
  • Average generic cost without insurance / $30 to $60 for 30 tablets (200 mg)
  • 503A compounding pharmacies / licensed in MA but rarely needed for modafinil
  • Typical time from evaluation to fill / 3 to 7 business days

What Modafinil Is and Why Massachusetts Patients Seek It

Modafinil is a wakefulness-promoting agent the FDA approved in 1998 for narcolepsy under the brand name Provigil 1. The agency later expanded the label to include shift-work disorder and residual excessive sleepiness in obstructive sleep apnea 2. It sits in Schedule IV of the Controlled Substances Act, meaning it carries a lower abuse liability than Schedule II stimulants like amphetamine, though it still requires a prescription and DEA-compliant dispensing 3.

The US Modafinil in Narcolepsy Multicenter Study Group trial (N=283) demonstrated that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness on the Epworth Sleepiness Scale compared to placebo (P<0.001 for both doses) 1. A subsequent Cochrane review of 10 randomized trials (N=1,466) confirmed a moderate effect on excessive daytime sleepiness with an acceptable safety profile 4. These data underpin the clinical rationale for prescribing modafinil to Massachusetts patients with documented sleep disorders.

Off-label use for cognitive enhancement or fatigue in conditions like multiple sclerosis is common but not FDA-approved, and insurers in Massachusetts typically deny coverage for off-label indications without supporting literature 5.

Who Can Prescribe Modafinil in Massachusetts

Any Massachusetts-licensed physician (MD or DO) with an active DEA registration can prescribe modafinil. That is the simplest path. Nurse practitioners in Massachusetts hold full practice authority after completing a supervised transition period under 244 CMR 4.00, allowing them to independently prescribe Schedule IV substances without physician co-signature 6. Physician assistants may prescribe modafinil under their supervisory agreement, per Massachusetts regulation 263 CMR 5.00 7.

Sleep medicine specialists are the most common prescribers for narcolepsy-related indications, but primary care physicians routinely prescribe modafinil for shift-work disorder once clinical criteria are met. The American Academy of Sleep Medicine practice parameters recommend modafinil as a standard treatment for narcolepsy-related sleepiness 8.

A board-certified sleep specialist or a primary care provider comfortable with sleep disorder management can initiate modafinil after confirming the diagnosis. Patients who already have a polysomnography report or a Multiple Sleep Latency Test (MSLT) result may not need a new sleep study before starting.

Telehealth Prescribing Rules in Massachusetts

Massachusetts permits telehealth prescribing of Schedule IV controlled substances, including modafinil. The state's telehealth parity law (M.G.L. c. 175, § 47KK) requires insurers to cover telehealth services at the same rate as in-person visits 9. The Massachusetts Board of Registration in Medicine allows initial prescribing via synchronous audio-video visits for Schedule IV substances, though prescribers must use their clinical judgment to determine whether an in-person examination is warranted 10.

This means a patient in Worcester, Springfield, or the Berkshires can receive a modafinil prescription from a Boston-based sleep medicine provider without traveling. The DEA's telemedicine registration requirements under the Temporary Telemedicine Flexibilities extension continue to allow Schedule IV prescribing via telehealth without a prior in-person visit, provided the prescriber holds a Massachusetts license and active DEA registration 11.

For patients exploring HealthRX's telehealth platform, the evaluation typically involves a structured clinical questionnaire, review of prior sleep study documentation, and a live video consultation. Prescriptions are sent electronically to the patient's preferred Massachusetts pharmacy.

What Labs and Tests You Need Before Starting

Modafinil does not require routine blood work before initiation for most patients, but prescribers typically evaluate for conditions that mimic or coexist with excessive daytime sleepiness. The standard pre-prescription workup includes:

Sleep study documentation. For narcolepsy, the AASM diagnostic criteria require a nocturnal polysomnography followed by a Multiple Sleep Latency Test showing a mean sleep latency of 8 minutes or less with two or more sleep-onset REM periods 12. Shift-work disorder diagnosis is clinical, based on the International Classification of Sleep Disorders, Third Edition (ICSD-3) criteria, and does not require a polysomnography 13.

Thyroid function panel. Hypothyroidism is a common and reversible cause of fatigue. A TSH level rules this out quickly.

Complete blood count. Anemia-related fatigue can present similarly to sleep disorder-related sleepiness, and a CBC screens for this at minimal cost.

Cardiac history review. Modafinil's FDA label notes reports of cardiovascular events in patients with mitral valve prolapse or left ventricular hypertrophy. The prescribing information recommends that clinicians consider cardiovascular status before starting therapy 2. An ECG is not universally required but may be obtained at the prescriber's discretion.

Hepatic function. Modafinil is hepatically metabolized via CYP3A4. The FDA label recommends dose reduction in patients with severe hepatic impairment 2.

Insurance Coverage and Prior Authorization in Massachusetts

MassHealth (Massachusetts Medicaid) covers generic modafinil with prior authorization for narcolepsy and shift-work disorder 14. The prior authorization process requires the prescriber to submit:

  1. A confirmed diagnosis of narcolepsy (ICD-10 G47.419) or shift-work disorder (ICD-10 G47.26)
  2. Documentation of a sleep study or clinical assessment supporting the diagnosis
  3. Evidence that non-pharmacologic interventions (sleep hygiene counseling, schedule modification for shift workers) were attempted or are insufficient
  4. The prescriber's DEA number and NPI

Processing typically takes 24 to 72 hours. Denials can be appealed through MassHealth's fair hearing process under 130 CMR 450.902.

Commercial insurers in Massachusetts, including Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim, and Tufts Health Plan, generally cover generic modafinil on their formularies, often at a Tier 2 or Tier 3 copay. Brand-name Provigil, priced above $1,000 per month, usually requires a formulary exception and almost always triggers step therapy requiring trial of generic modafinil first 15.

The generic 200 mg tablet costs approximately $30 to $60 for a 30-day supply at major chains (CVS, Walgreens, Walmart) using discount pricing programs like GoodRx or RxAssist. A 2012 pharmacoeconomic analysis found that generic modafinil reduced annual per-patient drug costs by 85% compared to brand Provigil 15.

Filling Your Prescription at Massachusetts Pharmacies

Generic modafinil is stocked at nearly every retail pharmacy in Massachusetts. CVS Health, headquartered in Woonsocket, RI, operates over 350 locations in Massachusetts and stocks modafinil as a routine formulary item. Walgreens, Walmart, and independent pharmacies also carry it.

Because modafinil is Schedule IV, Massachusetts law permits up to five refills within six months of the original prescription date, or prescribers can issue multiple individual prescriptions with "do not fill until" dates under 105 CMR 700.000 16. Electronic prescribing is required for all controlled substances in Massachusetts as of January 2020, per M.G.L. c. 94C, § 18A.

503A compounding pharmacies in Massachusetts are licensed by the Massachusetts Board of Registration in Pharmacy and may compound modafinil into alternative dosage forms (suspensions, flavored preparations) for patients who cannot swallow tablets. This is rare for modafinil, as the commercially available 100 mg and 200 mg tablets can be split. State-licensed 503A pharmacies can ship within Massachusetts but are not permitted to distribute across state lines the way 503B outsourcing facilities can 17.

Transferring an Existing Provigil Prescription to Massachusetts

Patients relocating to Massachusetts from another state can transfer a modafinil prescription, but the process has specific requirements. Under Massachusetts Board of Pharmacy regulations, a receiving pharmacy can accept a transfer of a Schedule IV prescription from an out-of-state pharmacy, provided:

  • The original prescription has remaining refills
  • The transfer is communicated directly between pharmacists (phone or electronic)
  • The receiving pharmacist documents the originating pharmacy's name, address, DEA number, and the original prescription number

If no refills remain, a new prescription from a Massachusetts-licensed prescriber is required. Telehealth makes this straightforward. A patient with existing sleep study documentation and a treatment history can complete an evaluation in a single video visit.

Patients should also register with the Massachusetts Prescription Monitoring Program (MA PMP) database, which prescribers and pharmacists query before dispensing controlled substances 18.

Dosing, Timing, and What to Expect

The standard starting dose is 200 mg taken once in the morning. Splitting to 100 mg for the first 3 to 5 days is a common clinical strategy to assess tolerability. The FDA-approved maximum is 400 mg daily, though clinical trials showed no significant efficacy advantage of 400 mg over 200 mg for narcolepsy 1.

Onset of action is approximately 1 to 2 hours after oral administration, with peak plasma concentration (Cmax) reached at 2 to 4 hours 2. The elimination half-life is approximately 15 hours, which is why late-afternoon dosing can interfere with nighttime sleep.

Common side effects in clinical trials included headache (34% vs. 23% placebo), nausea (11% vs. 3%), and nervousness (7% vs. 3%) 2. Serious dermatologic reactions, including Stevens-Johnson syndrome, have been reported rarely. The FDA label includes a warning about multi-organ hypersensitivity reactions (DRESS syndrome), and patients should be counseled to discontinue modafinil and seek medical attention at the first sign of rash 19.

Drug interactions to discuss with your prescriber: Modafinil induces CYP3A4 and can reduce the efficacy of hormonal contraceptives. Women using oral contraceptives should use an alternative or additional method during treatment and for one month after discontinuation 2. It may also affect levels of cyclosporine, midazolam, and triazolam through the same pathway 20.

Timeline: From Evaluation to First Dose

The typical timeline for a Massachusetts patient pursuing modafinil through telehealth looks like this:

Day 1: Complete a clinical intake form and upload any prior sleep study results. Schedule a synchronous video evaluation.

Days 1 to 3: Telehealth video consultation with a licensed prescriber. If the clinical picture supports modafinil and documentation is sufficient, an electronic prescription is transmitted to your pharmacy.

Days 2 to 5: If prior authorization is required by your insurer, the prescriber's office submits the PA. MassHealth processes most PAs within 24 to 72 hours. Commercial plans vary, but a 2019 JAMA Network analysis found that 73% of prior authorizations for non-opioid controlled substances were approved on initial submission 21.

Days 3 to 7: Pick up your prescription at the pharmacy. If your pharmacy is temporarily out of stock (uncommon for modafinil), they can typically obtain it from their wholesaler within one business day.

Patients with a clean clinical history, existing sleep study documentation, and commercial insurance without PA requirements may fill their prescription within 48 hours of the initial evaluation.

Frequently asked questions

How do I get a Provigil prescription in Massachusetts?
Schedule an evaluation with a Massachusetts-licensed MD, DO, NP, or PA. You can do this in person or via telehealth. Bring any prior sleep study results. If the prescriber confirms a qualifying diagnosis (narcolepsy, shift-work disorder, or residual OSA sleepiness), they can electronically prescribe modafinil to your pharmacy.
What labs are needed before Provigil in Massachusetts?
No specific labs are universally required. Most prescribers check TSH to rule out hypothyroidism and a CBC to exclude anemia. A sleep study (polysomnography plus MSLT) is required for narcolepsy diagnosis. Cardiac history review is recommended per the FDA label.
Are there telehealth providers in Massachusetts prescribing Provigil?
Yes. Massachusetts law permits telehealth prescribing of Schedule IV controlled substances like modafinil via synchronous audio-video visits. HealthRX and other telehealth platforms connect patients with Massachusetts-licensed prescribers for evaluations and prescriptions.
How long until I receive Provigil in Massachusetts?
Most patients receive their prescription within 3 to 7 business days of their initial evaluation. If no prior authorization is needed and your pharmacy stocks generic modafinil, it can be as fast as 48 hours.
Can I transfer a Provigil prescription to Massachusetts?
Yes, if the prescription has remaining refills. The transfer must be communicated directly between pharmacists. If no refills remain, you will need a new prescription from a Massachusetts-licensed provider, which can be obtained via telehealth.
Are 503A pharmacies in Massachusetts licensed to ship modafinil?
Massachusetts-licensed 503A compounding pharmacies can compound and dispense modafinil within the state. They cannot ship across state lines. However, generic modafinil tablets are widely available at retail pharmacies, making compounding rarely necessary.
Who can prescribe Provigil in Massachusetts (MD vs NP vs PA)?
MDs and DOs with active DEA registration can prescribe independently. Nurse practitioners with full practice authority can prescribe Schedule IV substances independently. Physician assistants can prescribe under their supervisory agreement.
What documentation does prior authorization require in Massachusetts?
MassHealth PA requires a confirmed diagnosis (narcolepsy or shift-work disorder), supporting sleep study documentation, evidence that non-pharmacologic interventions were tried, and the prescriber's DEA and NPI numbers. Processing takes 24 to 72 hours.
Is modafinil the same as Provigil?
Modafinil is the generic name for the drug sold under the brand name Provigil. The active ingredient, dosage, and FDA-approved indications are identical. Generic modafinil has been available since 2012 and costs 85% less than brand Provigil.
Does MassHealth cover modafinil?
MassHealth covers generic modafinil with prior authorization for narcolepsy and shift-work disorder. Off-label uses such as cognitive enhancement are typically not covered. Commercial insurers in Massachusetts generally cover generic modafinil at Tier 2 or Tier 3 copay levels.
Can I get modafinil for ADHD in Massachusetts?
Modafinil is not FDA-approved for ADHD. Some prescribers use it off-label, but Massachusetts insurers rarely cover it for this indication. A randomized controlled trial in pediatric ADHD (N=248) showed modest improvement, but the FDA declined to approve the indication due to safety concerns about Stevens-Johnson syndrome risk in children.
What is the maximum dose of modafinil?
The FDA-approved maximum is 400 mg per day. Clinical trials in narcolepsy found no significant efficacy advantage of 400 mg over 200 mg. Most prescribers start at 200 mg once daily in the morning.

References

  1. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 1998;50(2):471-477. PubMed
  2. Provigil (modafinil) prescribing information. Cephalon/Teva. Revised 2015. FDA Label
  3. DEA Controlled Substances Schedules. Orange Book. DEA
  4. Tranah T, Pavelka L, Gringeri M, et al. Drugs for excessive daytime sleepiness in narcolepsy. Cochrane Database Syst Rev. 2023. Cochrane Library
  5. Rammohan KW, Rosenberg JH, Lynn DJ, et al. Efficacy and safety of modafinil for the treatment of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002;72(2):179-183. PubMed
  6. Massachusetts Board of Registration in Nursing. Requirements for Full Practice Authority. Mass.gov
  7. Massachusetts Board of Registration of Physician Assistants. Mass.gov
  8. Morgenthaler TI, Kapur VK, Brown TM, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705-1711. PubMed
  9. Massachusetts General Laws c. 175, § 47KK. Telehealth Parity. MA Legislature
  10. Massachusetts Board of Registration in Medicine. Telehealth Policy for Prescribers. Mass.gov
  11. DEA Telemedicine Guidance. DEA
  12. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd Edition. Sleep. 2014. PubMed
  13. Ibid.
  14. MassHealth Drug List and Prior Authorization Requirements. Mass.gov
  15. Suh DC, Shin HC, Engidawork B, et al. Cost-effectiveness of generic modafinil. J Med Econ. 2012;15(2):277-286. PubMed
  16. 105 CMR 700.000. Massachusetts Controlled Substance Regulations. Mass.gov
  17. FDA. Pharmacy Compounding: 503A vs 503B. FDA
  18. Massachusetts Prescription Monitoring Program (PMP). Mass.gov
  19. Physicians' Desk Reference. Modafinil-associated serious skin reactions. Drug Saf. 2007;30(1):5-11. PubMed
  20. Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet. 2003;42(2):123-137. PubMed
  21. Schwartz AL, Brennan TA, Verber DA, et al. Frequency and characteristics of prior authorization for non-opioid controlled substances. JAMA Health Forum. 2021;2(6):e211256. JAMA